Skip to main content

Viral and Host Determinants of Neurovirulence of HIV-1 Infection

  • Chapter
Drugs of Abuse, Immunomodulation, and Aids

Abstract

HIV-1 infection of the brain is often associated with impairment in cognition, motor performance, and behavior in adults, and in addition, slowed milestones of brain growth and development in children(33,42,79). These may range in severity from subtle, mild deficits to conspicuous decline in performance diagnosed as HIV-1 associated dementia (HAD) and may occur in about 25% of AIDS patients independently of opportunistic infections, neoplasms, or metabolic derangements(44,85,104,120). However, close correlations between the clinical course of HAD and laboratory findings are not yet established(43,l40).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson DC, Wildemann B, Sasaki M et al. Immunologic NO Synthase: elevation in severe AIDS dementia and Induction by HIV-1 gp41. Science 1996; 274:1917–1921.

    Article  PubMed  CAS  Google Scholar 

  2. Adamson DC, Dawson TM, Zink MC, Clements JE, Dawson VL. Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med 1996; 2:417–428.

    Article  PubMed  CAS  Google Scholar 

  3. Adle-Biassette H, Levy Y, Colombel M et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 1995; 21:218–227.

    Article  PubMed  CAS  Google Scholar 

  4. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RAN-TES, MIP-lα, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955–1958.

    Article  PubMed  CAS  Google Scholar 

  5. An SF, Giometto B, Scaravilli F. HIV-1 DNA in Brains in AIDS and Pre-AIDS: Correlation with the Stage of Disease. Ann Neurol 1996; 40:611–617.

    Article  PubMed  CAS  Google Scholar 

  6. Bagasra O, Seshamma T, Pomerantz R, Hansen J. In-Situ PCR & Hybridization to Detect Low-Abundance Nucleic Acid Targets. Current protocols in Molecular Biology 1995, Sections 14.8.1—14.8.23, Supplement 31. John Wiley & Sons, New York, NY.

    Google Scholar 

  7. Bell JE, Donaldson YK, Lowrie S et al. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996; 10:493–499.

    Article  PubMed  CAS  Google Scholar 

  8. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, Doms RW. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996; 70:6288–6295.

    PubMed  CAS  Google Scholar 

  9. Black RJ, Rausch DM. NeuroAIDS, current understanding and future directions. J Neuro Virol 1996; 2:230–233.

    CAS  Google Scholar 

  10. Blumberg BM, Gelbard HA, Epstein LG. HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res 1994; 32:253–267.

    Article  PubMed  CAS  Google Scholar 

  11. Boni J, Emmerich BS, Leib SL, Wiestler OD, Schupbach J, Kleihues P. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 1993; 43:1813–1817.

    Article  PubMed  CAS  Google Scholar 

  12. Brack-Werner R, Kleinschmidt A, Ludvigsen A et al. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 1992; 6:273–285.

    Article  PubMed  CAS  Google Scholar 

  13. Brew BJ. The pathogenesis of the neurological complications of HIV-1 Infection. Genitourin Med. 1993; 69:333–340.

    PubMed  CAS  Google Scholar 

  14. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS Dementia Complex and HIV-1 Brain Infection: Clinical-Virological Correlations. Ann Neurol 1995; 38:563–570.

    Article  PubMed  CAS  Google Scholar 

  15. Budka H, Wiley CA, Kleihues P et al. HIV-Associated disease of the Nervous System: Review of Nomenclature and proposal for Neuropathology-Based Terminology. Brain Pathology 1991; 1:143–152.

    Article  PubMed  CAS  Google Scholar 

  16. Choe H, Farzan M, Sun Y et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135–1148.

    Google Scholar 

  17. Cheng-Mayer C, Levy JA. Distinct biological and serological properties of human immunodeficiency virus from the brain. Ann Neurol 1988; 21(Suppl.):S58–S61

    Article  Google Scholar 

  18. Chesebro B, Wehrly K, Nishio J, Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992; 66:6547–6554.

    PubMed  CAS  Google Scholar 

  19. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo R, Lusso P. Identification of RANTES, MlP-lα, MlP-β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells. Science 1995; 270:1811–1815.

    Article  PubMed  CAS  Google Scholar 

  20. Cullen BR. Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986; 46:973–982.

    Article  PubMed  CAS  Google Scholar 

  21. Dawson VL, Dawson TM, Uhl GR, Snyder SH. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993; 90:3256–3259.

    Article  PubMed  CAS  Google Scholar 

  22. Dean M, Carrington M, Winkler C et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273:1856–1862.

    Article  PubMed  CAS  Google Scholar 

  23. Delagado S, Shapshak P, Stewart RV, Rodriguez de la Vega P, Benjamin S, and Bradley W. Heterogeneity of macrophages in the peripheral nervous system in HIV-1 infected individuals. 1997; in press.

    Google Scholar 

  24. Deng HK, Choe S, Ellmeier W et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381:661–666.

    Article  PubMed  CAS  Google Scholar 

  25. Di Stefano M, Wilt S, Gray F, Dubois-Dalcq M, Chiodi F. HIV Type 1 V3 Sequences and the Development of Dementia during AIDS. AIDS Res Hum Retrov 1996; 12:471–476.

    Article  Google Scholar 

  26. Doranz BJ, Rucker J, Yi Y et al., A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CDR-5, CDR-3, and CKR-2b as fusion cofactors. Cell 1996; 85:1149–1158.

    Article  PubMed  CAS  Google Scholar 

  27. Dragic T, Liwin V, Allaway GP et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CDR-5. Nature 1996; 381:667–673.

    Article  PubMed  CAS  Google Scholar 

  28. Epstein LG, Sharer LR, Joshi VV, Fojas MM, Koenigsburger MR, Oleslce JM. Progressive Encephalo-pathy in Children with Acquired Immune Deficiency Syndrome. Ann Neurol 1985; 17:488–496.

    Article  PubMed  CAS  Google Scholar 

  29. Everall I, Luthert P, Lantos P. A review of Neuronal Damage in Human Immunodeficiency Virus Infection: Its Assessment, Possible Mechanism and Relationship to Dementia. J. Neuropathol Exp Neurol 1993; 52:561–566.

    Article  PubMed  CAS  Google Scholar 

  30. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 Entry Cofactor: Functional cDNA Cloning of Seven Transmembrane, GProtein-Coupled Receptor. Science 1996; 272:872–877.

    Article  PubMed  CAS  Google Scholar 

  31. Finkel TW, Tudor-Williams G, Banda HK et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Med 1995; 1:118–120.

    Article  Google Scholar 

  32. Fujimura RK, Bockstahler LE. PCR Method for Determining Ratios of HIV Proviral DNA to Cellular Genomic DNA in Brain Tissue of HIV-Infected Patients. J Vir Method 1995; 55:309–325.

    Article  CAS  Google Scholar 

  33. Fujimura RK, Bockstahler LE, Goodkin K, Werner T, Brack-Werner R, Shapshak P. Neuropathology and Virology of HIV Associated Dementia. Rev in Med Virol 1996; 6:141–150.

    Article  CAS  Google Scholar 

  34. Fujimura RK, Shapshak P, Feaster D, Epler M, Goodkin K. A Rapid Method for Comparative Quatitiative Polymerase Chain Reaction of HIV-1 Proviral DNA Extracted from Cryopreserved Brain Tissues. J Vir Method 1997; 67:177–187.

    Article  CAS  Google Scholar 

  35. Fujimura RK, Goodkin K, Petito CK, Douyon R, Feaster DJ, Concha M, Shapshak P. HIV-1 Proviral DNA Load Across Neuroanatomical Regions of Individuals with evidence for HIV-1 Associated Dementia. J AIDS HR, 1997, in press.

    Google Scholar 

  36. Gelbard HA, James HJ, Sharer LR et al., Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 1995; 21:208–217.

    Article  PubMed  CAS  Google Scholar 

  37. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R. The neuropathogenesis of AIDS dementia complex. AIDS 1997; 11(suppl A): S35–S45.

    Article  PubMed  Google Scholar 

  38. Giulian D, Baker TJ, Characterization of ameboid microglia isolated from developing mammalian brain, J Neurosci, 6, 2163–2178, 1986.

    PubMed  CAS  Google Scholar 

  39. Glass JD, Wesselingh SL, Seines OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associ-ated dementia. Neurology 1993; 43:2230–2237.

    Article  PubMed  CAS  Google Scholar 

  40. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical Quantitation of Human Immunodeficiency Virus in the Brain: Correlations with Dementia. Ann Neurol 1995; 38:755–762.

    Article  PubMed  CAS  Google Scholar 

  41. Goodkin K, Antoni MH, Helder L, Sevin B. Psychoneuroimmunological aspects of disease progression among women with human papilloma virus-associated cervical dysplasia and human immunodeficiency virus type 1 co-infection. Internatl J Psych Med 1993; 23:119–147.

    Article  CAS  Google Scholar 

  42. Goodkin K. Complications of the central and peripheral nervous systems. In: M. Forstein (Chairman, Commission on AIDS, ed). HIV-Related Neuropsychiatric Complications and Treatments. HIV/AIDS Training Curriculum. Am Psychiat Assoc, Washington DC. 1995: pp 1–103.

    Google Scholar 

  43. Goodkin K, Wilkie FL, Concha M et al. Subtle Neuropsychological Impairment and Minor Cognitive-Motor Disorder in HIV-1 Infection: Neuroradiological, Neuropsychological, Neuroimmunological, and Virological Correlates. In Neuroimaging Clinics of North America. MJD Post (ed). 1997; 7(3):561–579.

    Google Scholar 

  44. Goodkin K, Shapshak P, Fujimura RK et al. Immune Function, Brain, and HIV-1 Infection. In Psychnoneuroimmunology: Stress, Mental Disorders and Health. Goodkin K and Visser APh (Eds). American Psychiatric Press Inc: Washington DC 1997, in press.

    Google Scholar 

  45. Goodkin K, Shapshak P, Metsch L. et al. Cocaine Abuse and HIV-1: Epidemiology and Neuropathogenesis. J Neuroimmunol. 1997, in press.

    Google Scholar 

  46. Gray F, Adle-Biassette H, Levy Y, Wingertsmann L, Hery C., Tardieu M. Neuronal apoptosis in the course of human immunodeficiency. Bull Acad Natl Med 1996; 180:1855–1867.

    PubMed  CAS  Google Scholar 

  47. Green M, Loewenstein PM. Autonomous functional domains for chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988; 55:1179–1188.

    Article  PubMed  CAS  Google Scholar 

  48. Haynes B, Pantaleo G, Fauci A. Toward an Understanding of the Correlates of Protective Immunity to HIV Infection. Science 1996; 271:324–328.

    Article  PubMed  CAS  Google Scholar 

  49. He J, Chen Y, Farzan M et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997; 385:645–649.

    Article  PubMed  CAS  Google Scholar 

  50. Hesselgesser J, Halks-Miller M, DelVecchio V et al. CD4-independent association between HIV-1 gpl20 and CXCR4: functional chemokine receptor are expressed in human neurons. Curr Biol 1997; 7:112–121.

    Article  PubMed  CAS  Google Scholar 

  51. Ho DD. Viral Counts Count in HIV Infection. Science 1996; 272:1124–1125.

    Article  PubMed  CAS  Google Scholar 

  52. Horuk R. Molecular properties of the chemokine receptor family. Trends Pharmacol Sci 1994; 15:159–165.

    Article  PubMed  CAS  Google Scholar 

  53. Horuk R, Martin AW, Wang Z et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 1997; 158:2882–2890.

    PubMed  CAS  Google Scholar 

  54. Johnson RT, Glass JD, McArthur JC, Chesebro BW. Quantitation of Human Immunodeficiency Virus in Brains of Demented and Nondemented patients with Acquired Immunodeficiency Syndrome. Ann Neurol 1996; 39:392–395.

    Article  PubMed  CAS  Google Scholar 

  55. Keys B, Daris J, Fadeel B, Valentin A, Norkrans G, Hagberg L, Chiodi F. V3 Sequences of Paired HIV-1 Isolates from Blood and Cerebrospinal Fluid Cluster According to Host and Show Variation Related to the Clinical stage of Disease. Virology 1993; 196:475–483.

    Article  PubMed  CAS  Google Scholar 

  56. Kieburtz D, Ketonen L, Cox C., et al. Cognitive Performance and Regional Brain Volume in Human Immunodeficiency Virus Type 1 Infection. Arch Neurol 1996; 53:155–158.

    Article  PubMed  CAS  Google Scholar 

  57. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233:1089–1093.

    Article  PubMed  CAS  Google Scholar 

  58. Kohleisen B, Neumann M, Herrmann R, Brack-Werner R, Krohn KJE, Ovod V, Ranki A, Erfle V. Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS 1992; 6:1427–1436.

    Article  PubMed  CAS  Google Scholar 

  59. Kolson DL, Collman R, Hrin R, et al. Human immunodeficiency virus type I Tat activity in human neuronal cells: uptake and trans-activation. J Gen Virol 1994; 75:1927–1934.

    Article  PubMed  CAS  Google Scholar 

  60. Kong L-Y, Wilson BC, McMillian MK, Bing G, Hudson PM, Hong J-S. The Effects of the HIV-1 Envelope Protein gpl20 on the Production of Nitric Oxide and Proinfammatory Cytokines in Mixed Glial Cell Cultures. Cell Immunol 1996; 172:77–83.

    Article  PubMed  CAS  Google Scholar 

  61. Korber BT, Kunstman KJ, Patterson BK et al. Genetic differences between blood-and brain-derived viral sequences from human immuno-deficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68:7467–7481.

    PubMed  CAS  Google Scholar 

  62. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen ISY. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987; 236:819–822.

    Article  PubMed  CAS  Google Scholar 

  63. Krajewski S, James HJ, Ross J et al. Expression of pro-and anti-apoptosis gene products in brains from paediatric patients with HIV-1 encephalitis. Neuropathol Appl Neurobiol 1997; 23:242–253.

    Article  PubMed  CAS  Google Scholar 

  64. Kuiken CL, Goudsmit J, Weiller GF, Armstrong JS, Hartman S, Portegies P, Dekker J, Cornelissen M. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J Gen Virol 1995; 76:175–180.

    Article  PubMed  CAS  Google Scholar 

  65. Kuiken CL, Cornelissen MT, Zorgdrager F, Hartman S, Gibbs AJ, Goudsmit J. Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution. J Gen Virol 1996; 77:783–792.

    Article  PubMed  CAS  Google Scholar 

  66. Kure K, Weidenheim KM, Lyman WD, Diskson DW, Morphology and distribution of HIV-1-positive mi-croglia in subacute AIDS encephalitis: pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (Berl) 1990; 80:393–400.

    Article  CAS  Google Scholar 

  67. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995; 268:429–431.

    Article  PubMed  CAS  Google Scholar 

  68. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured brain tissue: identification of replication competent and defective viral genomes. J Virol 1991; 65:3973–3985.

    PubMed  CAS  Google Scholar 

  69. Lipton SA, Gendelman HE. Dementia Associated with the Acquired Immunodeficiency Syndrome. NEJ Med 1995; 332:934–940.

    Article  CAS  Google Scholar 

  70. Liu R, Paxton WA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367–377.

    Article  PubMed  CAS  Google Scholar 

  71. Ma M, Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 1997; 71:2495–2499.

    PubMed  CAS  Google Scholar 

  72. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of Human Immunodeficiency Virus-associated Neocortical Damage. Ann Neurol 1992; 32:321–329.

    Article  PubMed  CAS  Google Scholar 

  73. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA. Selective Neuronal Vulnerability in HIV Encephalitis. J Neuropath Experi Neurology 1992; 51:585–593.

    Article  CAS  Google Scholar 

  74. Masliah E, Achim CL, Ge N, DeTeresa R, Wiley CA. Cellular Neuropathology in HIV Encephalitis. HIV, AIDS and the Brain, eds RW Price and SW Perry, Raven press, Ltd., NY., 1994; pp. 119–131.

    Google Scholar 

  75. Masliah E, Ge N, Achim CL, DeTeresa R, and Wiley, CA. Patterns of Neurodegeneration in HIV Encephalitis. J Neuro-AIDS 1996; 1:161–173.

    Article  CAS  Google Scholar 

  76. McCloskey TW, Ott M, Tribble E, et al. Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol 1997; 158:1014–1019.

    PubMed  CAS  Google Scholar 

  77. McCoy C, Inciardi J. Sex, Drugs, and the Continuing Spread of AIDS. 1995; Roxbury Publishing Co, Los Angeles.

    Google Scholar 

  78. McNicholl JM, Smith DK, Qari SH, Hodge T. Host Genes and HIV: The Role of the Chemokine Receptor Gene CCR5 and its Allele (A32 CCR5) Emerging Infectious Diseases 1997; 3:261–271.

    Article  PubMed  CAS  Google Scholar 

  79. Melton ST, Kirkwood CK, Ghaemi SN. Pharmacotherapy of HIV dementia. Ann Pharmacother 1997; 31:457–473.

    PubMed  CAS  Google Scholar 

  80. Mollace V, Colasanti M, Persichini T, Bagetta G, Lauro GM, Nistico G. HIV gpl20 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun 1993; 194:439–445.

    Article  PubMed  CAS  Google Scholar 

  81. Morgan MJ, Kimes AS, London ED. Possible roles for nitric oxide in AIDS and associated pathology. Med Hypotheses 1992; 38:189–193.

    Article  PubMed  CAS  Google Scholar 

  82. Myers G, Korber BT, Foley B, Jeang KT, Mellors JW, Wain-Hobson S. Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1996.

    Google Scholar 

  83. Nassogne MC, Louahed J, Evrard P, Courtoy PJ. Cocaine induces apoptosis in cortical neurons of fetal mice. J Neurochem 1997; 68:2442–2450.

    Article  PubMed  CAS  Google Scholar 

  84. Nath A, Psooy K, Martin C et al. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996; 70:1475–1480.

    PubMed  CAS  Google Scholar 

  85. Navia BA, Jordan BD, Price RW. The AIDS dementia complex. I. clinical features. Ann Neurol 1986; 19:517–524.

    Article  PubMed  CAS  Google Scholar 

  86. Navia BA, Cho E-S, Petito CD, Price RW. The AIDS dementia complex: II. neuropathology. Ann Neurol 1986; 19:525–

    Article  PubMed  CAS  Google Scholar 

  87. Neumann M, Felber BK, Kleinschmidt A, Froese B, Volker E, Pavlakis, GN, and Brack-Werner, R. Restriction of Human Immunodeficiency Virus Type 1 Production in a Human Astrocytoma Cell Line Is Associated with a Cellular Block in Rev Function. J Virol 1995; 69:2159–2167.

    PubMed  CAS  Google Scholar 

  88. New DR, Ma M Epstein LG, Nath A, Gelbard HA. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 1997; 3:168–173.

    Article  PubMed  CAS  Google Scholar 

  89. Nuovo GJ, Gallery F, MacConnell P, Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-a RNA in the central nervous system. Am. J. Path. 1994; 144:659–665.

    PubMed  CAS  Google Scholar 

  90. Oberfield SE, Cowan L, Levine LS et al. Altered Cortisol Response and Hippocampal Atrophy in Pediatric HIV Disease, J Acquir Immune Defic Syndr 1994; 7:57–62.

    PubMed  CAS  Google Scholar 

  91. O’Brien SJ, Dean M. In Search of AIDS-Resistance Genes. Sci Am 1997 (9) 44–51.

    Google Scholar 

  92. O’Brien TR, Winkler C, Dean M et al. HIV-1 infection in a man homozygous for CCR5Δ32. Lancet 1997; 349:1219.

    Article  PubMed  Google Scholar 

  93. Oltvai ZN, Millman CL, Korsmeyer SJ. bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74:609–619.

    Article  PubMed  CAS  Google Scholar 

  94. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen ISY. High levels of unintegrated HIV-1 DNA in brain tissue of AIDs dementia patients. Nature 1990; 343:85–89.

    Article  PubMed  CAS  Google Scholar 

  95. Pang S, Vinters HV, Akashi T, O’Brien WA, Chen ISY. HIV-1 Env Sequence Variation in Brain Tissue of patients with AIDS-Related Neurologic Disease. J Acquir immun Defic Syndr 1991; 4:1082–1092.

    CAS  Google Scholar 

  96. Patton HK, Benveniste EN, and Benos DJ. Astrocytes and the AIDS Dementia Complex. J Neuro-AIDS 1996; 1:111–131.

    Article  CAS  Google Scholar 

  97. Petito CK, Cho E-S, Lemann W, Navia BA, Price RW. Neuropathology of Acquired Immunodeficiency Syndrome (AIDS): Autopsy Review. J Neuropathol Exp Neurol 1986; 45:635–646.

    Article  PubMed  CAS  Google Scholar 

  98. Petito CK, Roberts B. Evidence of Apoptotic Cell Death in HIV Encephalitis. Am J Pathol 1995; 146:1121–1130.

    PubMed  CAS  Google Scholar 

  99. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, and Chesebro B. Demented and Nondemented Patients with AIDS Differ in Brain-Derived Human Immunodeficiency Virus Type 1 Envelope Sequences. J Virol 1994; 68:4643–4649.

    PubMed  CAS  Google Scholar 

  100. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Dewey R, and Chesebro B. Distinct HIV-1 env Sequences Are Associated with Neurotropism and Neurovirulence. Curr Topics Microbiol Immunol. 1995; 202:89–104.

    Article  CAS  Google Scholar 

  101. Portegies, P. The Neurology of HIV-1 Infection. 1995. Meditech Media LTD, London, publisher.

    Google Scholar 

  102. Portegies P. AIDS Dementia Complex: A Review. J Acquir Immune Defic Syndr. 1994; 7:S38–S49.

    PubMed  Google Scholar 

  103. Pulliam L, Herndier BG, Tang NM, McGrath MS. Human Immunodeficiency Virus-infected Macrophages Produce Soluble factors that Cause Histological and Neurochemical Alterations in Cultured Human Brains. J Clin Invest 1991; 87:503–512.

    Article  PubMed  CAS  Google Scholar 

  104. Raber J, Toggas SM, Lee S, Bloom FE, Epstein CJ, Mucke L. Central nervous system expression of HIV-1 gp 120 activates the hypothalamic-pituitary-adrenal axis: Evidence for involvement of NMDA receptors and nitric oxide synthase. Virology 1996; 226:362–373.

    Article  PubMed  CAS  Google Scholar 

  105. Ranki A, Nyberg M, Ovod V et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995; 9:1001–1008.

    Article  PubMed  CAS  Google Scholar 

  106. Saag MS, Holodniy M, Kuritzkes DR et al. HIV viral load markers in clinical practice. Nature Medicine 1996; 2:625–629.

    Article  PubMed  CAS  Google Scholar 

  107. Sabatier J-M, Vives E, Mabrouk K. Evidence for neurotoxicity of tat from HIV. J Virol 1991; 65:961–967.

    PubMed  CAS  Google Scholar 

  108. Saito Y, Sharer LR, Epstein LG et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44:474–481.

    Article  PubMed  CAS  Google Scholar 

  109. Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722–725.

    Article  PubMed  CAS  Google Scholar 

  110. Sapolsky RM, Kery LC, McEwen BS. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocrine Rev 1986; 7:284–301.

    Article  CAS  Google Scholar 

  111. Sastry KJ, Marin MC, Nehete PN, McConnell K, Elnaggar AK, McDonnell TJ. Expression of human immunodeficiency virus type 1 tat results in downregulation of Bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 1996; 13:487–493.

    PubMed  CAS  Google Scholar 

  112. Segal DM, Shapshak P, Zhang B-T, Crandall KA, Page B, Fujimura RK, Goodkin K, Douyon R, McCoy CB. Novel tetrameric tip motifs (APGK and VPGK) in the V3 loop of HIV-1 envelope sequences in blood and brain from two injection drug users in Miami, Florida. AIDS Res Hum Retrovir, Sequence Notes, 1997; in press.

    Google Scholar 

  113. Shah SM, Shapshak P, Rivers JE et al. Detection of HIV-1 in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovir 1996; 11:301–306.

    Article  CAS  Google Scholar 

  114. Shapshak P, Nagano I, Xin KQ et al. HIV-1 heterogeneity and cytokines: neuropathogenesis, in The Brain Immune Axis and Substance Abuse, B Sharp et al. (eds), Adv in Exp Med and Biol 1995; 373:Chapt 31, pp225–236.

    Google Scholar 

  115. Shapshak P, Crandall KA, Xin KQ, Goodkin K, Fujimura RK, Bradley W, McCoy CB et al, HIV-1 Neuropathogenesis and Abused Drugs: Current Views, Problems, and Solutions. Adv in Exp Med & Biol 1996; 374, Chapter 23, pp171–186. B. Sharp, T. Eisenstein, J. Madden, and H. Friedman, eds.

    Google Scholar 

  116. Sharer LR. Pathology of HIV-1 infection of the Central Nervous System. J Neuropathol Exp Neurol 1992; 51:3–11.

    Article  PubMed  CAS  Google Scholar 

  117. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci 1996; 93:3908–3913.

    Article  PubMed  CAS  Google Scholar 

  118. Sinclair E, Scaravilli F. Detection of HIV proviral DNA in cortex and white matter of AIDS brains by nonisotopic polymerase chain reaction: correlation with diffuse poliodystrophy. AIDS 1992; 6:925–932.

    Article  PubMed  CAS  Google Scholar 

  119. Sinclair E, Gray F, Ciardi A, Scaravilli F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J. Neuropathol. Exp. Neurol. 1994; 53:43–50.

    Article  PubMed  CAS  Google Scholar 

  120. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 1983; 14:403–418.

    Article  PubMed  CAS  Google Scholar 

  121. Stewart RV, Shapshak P, Matthews A et al. Effects of Cocaethylene on Surface Marker Expression of HIV-1-Infected Macrophages Isolated from Human Brain Using Antibody-Coated Magnetic Beads: A Preliminary study. Cell Vision 1997; 4:66–72.

    CAS  Google Scholar 

  122. Strizki JM, Albright AV, Sheng H, O’Conner M, Perrin L, and Gonzalez-Scarano F. Infection of Primary Human Microglia and Monocyte-Derived Macrophages with Human Immunodeficiency Virus Type 1 Isolates: Evidence of Differential Tropism. J Virol 1996; 70:7654–7662.

    PubMed  CAS  Google Scholar 

  123. Strizki JM, Turner JD, Collman RG, Hoxie J, Gonzalex-Scarano F. A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1 (89.6) but not the T-tropic isolate HIV-l(HxB). J Virol 1997; 71:5678–5683.

    PubMed  CAS  Google Scholar 

  124. Subbiah P, Mouton P, Fedor H, McArthur JC, Glass JD. Stereological Analysis of Cerebral Atrophy in Human Immunodeficiency Virus-associated Dementia. J Neuropath Exp Neurol. 1996; 55:1032–1037.

    PubMed  CAS  Google Scholar 

  125. Tabatabaie T, Stewart C, Pye Q, Kotake Y, Floyd RA. In Vivo trapping of Nitric Oxide in the Brain of Neonatal Rats Treated with the HIV-1 Envelope Protein gp 120: Protective Effects of α-Phenyl-tert-butylni-trone. Biochem Biophys Res Comm 1996; 221:386–390.

    Article  PubMed  CAS  Google Scholar 

  126. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, and Glass JD. Localization of HIV-1 in Human Brain Using Polymerase Chain Reaction/In Situ Hybridization and Immunocytochemistry. Ann Neurol 1996; 39:705–711.

    Article  PubMed  CAS  Google Scholar 

  127. Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL, Luthert P, Shaunak S. Circular forms of unitegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 1997; 71:2928–2933.

    PubMed  CAS  Google Scholar 

  128. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C, and the Seroco Study Group. HIV-1 infection in an individual homozygous for CCR5A32. Lancet 1997; 349:1219–1220.

    Article  PubMed  CAS  Google Scholar 

  129. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44:481–487.

    Article  PubMed  CAS  Google Scholar 

  130. Vitkovic L, da Cunha A. Role for astrocytosis in HIV-associated dementia. Curr Top Micorbiol Immunol 1995; 202:105–116.

    Article  CAS  Google Scholar 

  131. Watkins BA, Dorn HH, Kelly WB, Armstrong RC, Potts BJ, Michaels, F, Kufta CV, and Dubois-Dalcq M. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 1990; 249:549–553.

    Article  PubMed  CAS  Google Scholar 

  132. Westendorp MO, Frank R, Ochsenbauer C et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375:497–500.

    Article  PubMed  CAS  Google Scholar 

  133. Westervelt P, Trowbridge DB, Epstein LG, Bluberg BM, Li Y, Hahn BH, Shaw GM, Price RW, and Ratner L. Macrophage Tropism Determinants of Human Immunodeficiency Virus Type 1 in Vivo. J Virol 1992; 66:2577–2582.

    PubMed  CAS  Google Scholar 

  134. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., and Oldstone, M. B. A. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 1986; 83:7089–7093.

    Article  PubMed  CAS  Google Scholar 

  135. Wiley CA and Achim C. Human Immunodeficiency Virus Encephalitis is the Pathological Correlate of Dementia in Acquired Immunodeficiency Syndrome. Ann Neurol 1994; 36:673–676.

    Article  PubMed  CAS  Google Scholar 

  136. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 1997; 71:2059–2071.

    PubMed  CAS  Google Scholar 

  137. Xin K-Q, Shapshak P, Kawamoto S, Nagano I, McCoy CB, Okuda K. Highly divergent env Sequences of HIV-1 B Subtype with Two Novel V3 Loop Motifs Detected in an AIDS Patient in Miami, Florida. AIDS Res Hum Retrov (Sequence Notes) 1995; 11:1139–1141.

    Article  CAS  Google Scholar 

  138. Yoshioka M, Shapshak P, Sun NCJ. et al. Simultaneous detection of ferritin and HIV-1 in reactive microglia. Acta Neuropathol 1992; 84:297–306.

    Article  PubMed  CAS  Google Scholar 

  139. Yoshioka M, Bradley WG, Shapshak P, Nagano I, Stewart RV, Xin KQ, Srivastava AK, Nakamura S. Role of immune activation and cytokine expression in HIV-1 associated neurologic diseases, Adv Neuroimmu 1995; 5:335–358.

    Article  CAS  Google Scholar 

  140. Zeng J, Gendelman HE. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 1997; 10:319–325.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fujimura, R.K. et al. (1998). Viral and Host Determinants of Neurovirulence of HIV-1 Infection. In: Friedman, H., Madden, J.J., Klein, T.W. (eds) Drugs of Abuse, Immunomodulation, and Aids. Advances in Experimental Medicine and Biology, vol 437. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5347-2_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5347-2_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7439-8

  • Online ISBN: 978-1-4615-5347-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics